• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Breast Cancer

A 6-minute breathalyzer for breast cancer | MassDevice.com On Call

March 6, 2014 By Arezu Sarvestani Leave a Comment

MassDevice.com On Call

MASSDEVICE ON CALL — Diagnostics maker Menssana Research is making promising progress with a breath-test that the company says can identify at-risk breast cancer cases in just 6 minutes.

In a study of nearly 250 women at 3 centers in New Jersey, Washington and the Netherlands the test was able to accurately identify women with early stage breast cancer or with abnormal mammogram, Menssana said.

Filed Under: Diagnostics, News Well, Oncology, Women's Health Tagged With: Breast Cancer, Clinical Trials, Menssana Research, On Call

Update: Seno Medical closing in on funding goal, now at $35M

February 26, 2014 By Chris Walker Leave a Comment

Update: Seno Medical closing in on funding goal, now at $35M

Seno Medical is inching to its $39 million fundraising objective, having brought in $34.6 million in its Series C equity funding round.

San Antonio-based Seno has been at this for some time, and for this round has brought in MedCare Investment Funds as a lead investor. The funding is going towards the company’s U.S. pivotal study of the Imagio breast imaging device, as well as chasing CE Mark approval in Europe.

Filed Under: Funding Roundup, News Well, Oncology Tagged With: Breast Cancer, Seno Medical Instruments

VuComp wins FDA clearance for breast density measurement tool

December 24, 2013 By Chris Walker Leave a Comment

VuComp wins 510(k) clearance for breast density measurement tool

VuComp said it won 510(k) clearance from the FDA for its M-Vu breast density tool, which provides automated assessment of breast density from a digital mammogram.

The M-Vu uses advanced computer vision algorithms to evaluate the appearance of structures and textures in the breast to differentiate between fatty and dense regions. It then calculates a percentage of breast area that is dense, translating it to 1 of 4 density categories corresponding to the BI-RADS standard.

Filed Under: News Well, Oncology, Regulatory/Compliance Tagged With: Breast Cancer, VuComp Inc.

Philips wins 510(k) clearance for breast density measurement tool

December 23, 2013 By Chris Walker Leave a Comment

Philips wins 510(k) clearance for breast density measurement application

Philips (NYSE:PHG) said it landed 510(k) clearance for its spectral breast density measurement application, a new feature for its MicroDose SI full-field digital mammography system.

Filed Under: News Well, Oncology, Regulatory/Compliance Tagged With: Breast Cancer, Philips

FDA warns on aspirate test for breast cancer | MassDevice.com On Call

December 16, 2013 By MassDevice staff Leave a Comment

MassDevice.com On Call

MASSDEVICE ON CALL — The FDA cautioned women last week not to use nipple aspirate tests as a replacement for mammograms or other tests for breast cancer.

The federal watchdog agency said the aspirate tests, which draw fluid from the breast through the nipple, "an determine whether the fluid collected from the breast contains any abnormal cells."

Filed Under: News Well Tagged With: Breast Cancer, MassDevice.com, On Call

Breast cancer: Seno Medical hits 100th patient in Imagio pivotal trial

November 25, 2013 By Arezu Sarvestani Leave a Comment

Breast cancer: Seno Medical hits 100th patient in Imagio imaging trial

Seno Medical Instruments touted the 100th patient enrolled in a pivotal clinical study of the company’s Imagio system, an opto-acoustic breast imaging platform designed to help prevent unnecessary biopsies.

Filed Under: News Well, Oncology, Women's Health Tagged With: Breast Cancer, Clinical Trials, Seno Medical Instruments

Intact Medical raises $4M for breast biopsy device

November 15, 2013 By Chris Walker Leave a Comment

Intact Medical raises $4M for breast biopsy device

Intact Medical closed a $4 million equity funding round in support of its breast biopsy systems, the company revealed in regulatory filings.

The Framingham, Mass.-based device maker listed 11 unnamed investors who participated in the round.

Filed Under: Diagnostics, Funding Roundup, News Well, Women's Health Tagged With: Breast Cancer, Intact Medical

Germany’s BioCer lands E.U. win for mastectomy bra, U.S. win for hernia mesh

November 11, 2013 By Arezu Sarvestani Leave a Comment

Germany's BioCer lands FDA win for hernia mesh, E.U. win for mastectomy bra

German medical device maker BioCer this week touted regulatory wins in the U.S. and in the U.K. for devices in its TiO2Mesh line, including for its mastectomy bra and hernia repair mesh.

Filed Under: News Well, Oncology, Regulatory/Compliance, Women's Health Tagged With: BioCer Entwicklungs, Breast Cancer, CE Mark

How do you stop an aggressive breast cancer? Keep it from recycling

October 23, 2013 By MassDevice Leave a Comment


A mammography machine.

By Tom Ulrich

Filed Under: Blog, News Well, Oncology, Women's Health Tagged With: Boston Children's Hospital, Breast Cancer, Vector Blog

Preventive mastectomy may not do much good, study says | MassDevice.com On Call

October 8, 2013 By Arezu Sarvestani Leave a Comment

MassDevice On Call

MASSDEVICE ON CALL — Double mastectomy rates have doubled over the last 10 years, including some women who’ve opted to remove a healthy breast after discovering early-stage breast cancer in the other, but the extreme measure may not be doing them much good.

Filed Under: News Well, Oncology, Women's Health Tagged With: Breast Cancer, On Call

Breast cancer: Hologic touts ‘excellent’ results from 7-year MammoSite registry

October 4, 2013 By Arezu Sarvestani Leave a Comment

Breast cancer: Hologic touts 'excellent' results from 7-year MammoSite registry

Filed Under: News Well, Oncology, Radiosurgery/Radiation therapy, Women's Health Tagged With: Breast Cancer, Clinical Trials, Hologic, On Call

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Interim pages omitted …
  • Go to page 14
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS